Sun Pharma and US-based Pharmazz to introduce cerebral ischemic stroke drug in India

Under the terms of the agreement, Sun Pharma has been granted the rights to market Sovateltide in India using the brand name Tyvalzi™ (Sovateltide). In return, Pharmazz will receive upfront payments, milestone payments, and royalties as stipulated in the agreement.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/N4O8IYz
via